Compounds > ezogabine
Page last updated: 2024-09-03

ezogabine and glycerophosphoinositol 4,5-bisphosphate

ezogabine has been researched along with glycerophosphoinositol 4,5-bisphosphate in 5 studies

Compound Research Comparison

Studies
(ezogabine)		Trials
(ezogabine)		Recent Studies (post-2010)
(ezogabine)		Studies
(glycerophosphoinositol 4,5-bisphosphate)		Trials
(glycerophosphoinositol 4,5-bisphosphate)		Recent Studies (post-2010) (glycerophosphoinositol 4,5-bisphosphate)
383262413,38131,043

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (80.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Gamper, N; Huang, D; Linley, JE; Pettinger, L1
Gao, Z; Gu, M; Li, M; Nan, FJ; Yu, H; Zhou, P1
Duignan, KM; Hawryluk, JM; Kim, KS; Soh, H; Tzingounis, AV1
Kim, RY; Kurata, HT; Pless, SA1
Li, T; Shen, H; Wang, Y; Wu, K; Yue, Z; Zhang, F1

Other Studies

5 other study(ies) available for ezogabine and glycerophosphoinositol 4,5-bisphosphate

ArticleYear
M channel enhancers and physiological M channel block.
    The Journal of physiology, 2012, Feb-15, Volume: 590, Issue:4

    Topics: Aminopyridines; Animals; Bradykinin; Calcium; Carbamates; CHO Cells; Cricetinae; Cricetulus; Ganglia, Spinal; Hydrogen Peroxide; Inflammation; KCNQ Potassium Channels; Organometallic Compounds; Pain; Phenylenediamines; Phosphatidylinositol 4,5-Diphosphate; Pyridines; Rats; Rats, Wistar; Sensory Receptor Cells; Type C Phospholipases

2012
Phosphatidylinositol 4,5-bisphosphate alters pharmacological selectivity for epilepsy-causing KCNQ potassium channels.
    Proceedings of the National Academy of Sciences of the United States of America, 2013, May-21, Volume: 110, Issue:21

    Topics: Animals; Anticonvulsants; Carbamates; CHO Cells; Cricetinae; Cricetulus; Epilepsy; KCNQ2 Potassium Channel; KCNQ3 Potassium Channel; Keratolytic Agents; Mice; Mutation; Nerve Tissue Proteins; Neurons; Organometallic Compounds; Phenylenediamines; Phosphatidylinositol 4,5-Diphosphate; Pyridines; Signal Transduction

2013
The Voltage Activation of Cortical KCNQ Channels Depends on Global PIP2 Levels.
    Biophysical journal, 2016, Mar-08, Volume: 110, Issue:5

    Topics: Animals; Carbamates; Cerebral Cortex; Female; HEK293 Cells; Hippocalcin; Humans; Ion Channel Gating; KCNQ3 Potassium Channel; Male; Membrane Potentials; Mice, Inbred C57BL; Mice, Knockout; Neurons; Phenylenediamines; Phosphatidylinositol 4,5-Diphosphate; Pyramidal Cells

2016
PIP2 mediates functional coupling and pharmacology of neuronal KCNQ channels.
    Proceedings of the National Academy of Sciences of the United States of America, 2017, 11-07, Volume: 114, Issue:45

    Topics: Animals; Anticonvulsants; Carbamates; Ion Channel Gating; KCNQ2 Potassium Channel; KCNQ3 Potassium Channel; Neurons; Phenylenediamines; Phosphatidylinositol 4,5-Diphosphate; Phospholipids; Potassium Channels, Voltage-Gated; Xenopus laevis

2017
Structural Basis for the Modulation of Human KCNQ4 by Small-Molecule Drugs.
    Molecular cell, 2021, 01-07, Volume: 81, Issue:1

    Topics: Animals; Carbamates; Cryoelectron Microscopy; Humans; Indoles; KCNQ Potassium Channels; Mutation; Phenylenediamines; Phosphatidylinositol 4,5-Diphosphate; Protein Domains; Pyridines; Sf9 Cells; Spodoptera

2021